Clone/ABfeature:
(#14W13)
Antibodygeneration:
Producedfromseraofgoatspre-immunizedwithhighlypure(>98%)recombinantmM-CSF(MurineM-CSF).Anti-mM-CSFspecificantibodywaspurifiedbyaffinitychromatographyemployingimmobilizedmM-CSFmatrix.
Antigen:
RecombinantMouseM-CSF
StABIlity:
Thelyophilizedantibodyisstableforatleast2yearsfromdateofreceiptat-20°C.Thereconstitutedantibodyisstableforatleasttwoweeksat2-8°C.Frozenaliquotsarestableforatleast6monthswhenstoredat-20°C.
Reconstitution:
Reconstitutetheantibodywith500µlsterilePBSandthefinalconcentrationis200µg/ml.
Description:
M-CSF,alsoknownasCSF-1,isafour-αhelical-bundlecytokinethatistheprimaryregulatorofmacrophagesurvival,proliferationanddifferentiation.M-CSFisalsoessentialforthesurvivalandproliferationofosteoclast
Progenitors.M-CSFalsoprimesandenhancesmacrophagekillingoftumorcellsandmicroorganisms,regulatesthereleaseofcytokinesandotherinflammatorymodulatorsfrommacrophages,andstimulatespinocytosis.MCSFincreasesduringpregnancytosupportimplantationandgrowthofthedeciduaandplacenta.SourcesofMCSFincludefibroblasts,activatedmacrophages,endometrialsecretoryepithelium,bonemarrowstromalcells,andactivatedendothelialcells.TheM-CSFreceptor(c-fms)transducesitspleotropiceffectsandmediatesitsendocytosis.M-CSFmRNAsofvarioussizesoccur.FulllengthmouseMCSFtranscriptsencodea520aminoacid(aa)typeItransmembrane(TM)proteinwitha462aaextracellularregion,a21aaTMdomain,anda37aacytoplasmictailthatformsa140kDacovalentdimer.Differentialprocessingproducestwoproteolyticallycleaved,secreteddimers.OneisanNandOglycosylated86kDadimer,whiletheotherismodifiedbybothglycosylationandchondroitinsulfateproteoglycan(PG)togeneratea200kDasubunit.AlthoughPGmodifiedM-CSFcancirculate,itmaybeimmobilizedbyattachmenttotypeVcollagen.ShortertranscriptsencodeM-CSFthatlackscleavageandPGsitesandproducesanN-glycosylated68kDaTMdimerandaslowlyproduced44kDasecreteddimer.Althoughformsmayvaryinactivityandhalf-life,allcontaintheN-terminal150aaportionthatisnecessaryandsufficientforinteractionwiththeM-CSFreceptor.Thefirst229aaofmaturemouseMCSFshares87%,83%,82%,and81%aaidentitywithcorrespondingregionsofrat,dog,cow,andhumanMCSF,respectively.HumanMCSFisactiveinthemouse,butmouseM-CSFisreportedtobespecies-specific.
ReliaTech
成立于1999年。除其他研究产品外,公司还开发、生产和销售用于血管生成和淋巴管生成研究的高质量研究试剂。
ReliaTech GmbH (short for Receptor Ligand Technologies GmbH) is a post-genomic German biotechnology company founded in 1999. Besides other research products the company develops, produces and sells high quality research reagents for angiogenic and lymphangiogenic research.
品牌 | 货号 | 名称 | 规格 |
ReliaTech | 102-P102 | Adiponectin | 100 µg |
ReliaTech | 102-P102 | Adiponectin | 100 µg |
ReliaTech | 102-P104 | CRP | 100 µg |
ReliaTech | 100-442S | FGF-BP-1 | 5 µg |
ReliaTech | 100-442 | FGF-BP-1 | 25 µg |
ReliaTech | 10-437 | Follistatin like-protein 1/FSTL1 | 50 µg |
ReliaTech | R20-74 | G-CSF | 10 µg |
ReliaTech | 100-444S | GPR15L | 5 µg |
ReliaTech | 100-444 | GPR15L | 25 µg |
ReliaTech | S01-073S | ICOS Fc | 10 µg |